Prev Arrow Stocks

Alexandria Real Estate Equities Inc. ($ARE) Stock Forecast: Up 5.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Alexandria Real Estate Equities Inc.?

Alexandria Real Estate Equities (ARE) is a real estate investment trust (REIT) specializing in life science and technology campuses within urban innovation clusters. The company manages properties in prominent areas like Boston, San Francisco, and New York City.

Why is Alexandria Real Estate Equities Inc. going up?

ARE stock is up 5.1% on Aug 22, 2025 15:46

  • ARE stock experienced a notable upward trend today, possibly influenced by optimistic market sentiment and investor confidence in the company's future growth prospects.
  • Despite a 3% decrease following the recent earnings release, investors seem hopeful about ARE's potential recovery, fuelled by forthcoming earnings projections and the company's focused approach towards high-demand real estate sectors.
  • The positive stock movement may also be linked to general market patterns or industry-specific factors that are bolstering real estate investments, thereby boosting ARE's stock value.

ARE Price Chart

ARE Technical Analysis

ARE News

Alexandria Real Estate Equities ( ARE ) Down 3% Since Last Earnings Report: Can It Rebound?

Alexandria Real Estate Equities (ARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

https://www.zacks.com/stock/news/2740367/alexandria-real-estate-equities-are-down-3-since-last-earnings-report-can-it-rebound

0 Missing News Article Image Alexandria Real Estate Equities  ( ARE )  Down 3% Since Last Earnings Report: Can It Rebound?

Alexandria Real Estate Equities Inc. Price History

09.03.2025 - ARE Stock was down 8.0%

  • The bearish movement in ARE could be due to profit-taking by investors after a period of strong gains.
  • The bullish movement in SBA Communications (SBAC) might have attracted investors away from ARE, leading to a sell-off in the stock.
  • The positive outlook for SBAC based on FFO per share estimate revisions could have shifted investor focus towards this stock, causing a decline in ARE.
  • Investors may be rotating their investments from ARE to SBAC in anticipation of stronger potential returns, contributing to the bearish movement in ARE today.

28.00.2025 - ARE Stock was down 5.0%

  • The bearish movement in ARE's stock could be due to lower-than-expected performance in key metrics for the quarter ended December 2024.
  • Investors may have reacted negatively to projections that fell short of market estimates, leading to a sell-off of ARE shares.
  • Uncertainty surrounding the company's business performance in the current economic climate could have also contributed to the downward pressure on the stock.

16.01.2024 - ARE Stock was up 5.2%

  • ARE announced a $1.5 billion stock offering, indicating confidence in its future prospects.
  • The company has secured key financial agreements, further solidifying its position in the market.
  • AstraZeneca's $300 million investment in a cell therapy facility at Alexandria Centre for Life Science showcases the attractiveness of ARE's properties to major tenants.
  • The positive assessment of ARE as a standout in the life sciences real estate arena, with a commitment to innovation and sustainable growth, has likely contributed to the bullish market movement.

09.10.2023 - ARE Stock was down 5.0%

  • The bearish movement in ARE's stock today could be attributed to several factors:
  • 1. Reduced earnings forecasts: The recent report from Zacks Research, which lowered Q2 2024 earnings per share estimates for ARE, may have negatively impacted investor sentiment and contributed to the bearish movement.
  • 2. Insider selling: The large insider sell by ALEXANDRIA REAL ESTATE EQUITIES INC, the 10% owner of Applied Therapeutics, could have raised concerns among investors about the company's overall performance and future prospects.
  • 3. Price decline and valuation concerns: The decline in ARE's stock price over the past two years, as mentioned in two articles from Seeking Alpha, may have led some investors to question the company's long-term growth potential and fair valuation.
  • Overall, the combination of reduced earnings forecasts, insider selling, and valuation concerns could have influenced the bearish movement in ARE's stock today.

13.01.2024 - ARE Stock was down 5.3%

  • 1. AstraZeneca's $300 million investment: The significant investment in a cell therapy manufacturing facility at Alexandria's Rockville campus may have raised concerns about the financial implications for ARE. The potential impact on cash flow or shareholder dilution could be factors influencing the bearish movement.
  • 2. Short interest decline: The decrease in short interest suggests traders closing out bearish positions, potentially signaling a lack of confidence in the stock's near-term performance. This reduction in short interest could be putting downward pressure on the stock.
  • 3. Market sentiment: Investor concerns about the broader real estate sector or the life sciences industry outlook may have influenced selling decisions and contributed to the bearish movement.
  • 4. Lack of positive news: The absence of positive developments specific to Alexandria Real Estate Equities on the day could have also contributed to the bearish movement. Without any catalysts to drive investor interest, selling pressure may have been a factor.
  • In summary, factors such as concerns related to AstraZeneca's investment, declining short interest, overall market sentiment, and the absence of positive news could be attributed to the bearish movement in ARE's stock.

15.01.2024 - ARE Stock was up 5.2%

  • The upward movement in ARE's stock today can be attributed to the following factors:
  • 1. AstraZeneca's significant investment: A long-standing tenant of ARE, AstraZeneca has announced a $300 million investment in a next-generation cell therapy facility at the Alexandria Center for Life Science. This investment underscores the growth potential of ARE's properties and the confidence of a major industry player.
  • 2. Strong foothold in the life sciences sector: ARE's emphasis on establishing top-tier life science and tech hubs aligns with the ongoing trend of increased investment in biotech innovation. This strategic positioning appeals to investors seeking sustainable returns and substantial growth prospects.
  • 3. Leading presence in the Maryland life science ecosystem: AstraZeneca's investment announcement further solidifies ARE's leadership in the Maryland life science ecosystem. It showcases the company's dedication to innovation and growth, which is likely to draw more investors and drive up the stock price.
  • Overall, the positive movement in ARE's stock today stems from the news of AstraZeneca's investment and the company's strong positioning in the life sciences sector.

29.10.2023 - ARE Stock was up 8.1%

  • The bullish movement in ARE stock today can be attributed to the following factors:
  • 1. Expansion of Lilly Gateway Labs: The announcement of a new Lilly Gateway Labs location in partnership with Eli Lilly and Company indicates the company's commitment to supporting and accelerating the development of early-stage companies in the life science industry. This partnership and expansion could have sparked investor optimism about the potential growth and demand for lab space provided by Alexandria Real Estate Equities.
  • 2. Positive Outlook: The article highlighting the growth potential of Alexandria Real Estate and suggesting that the stock is a buy might have also influenced investor sentiment. The positive outlook for the company's prospects in the life sciences sector could have contributed to the bullish movement in the stock.
  • 3. Strong Strategic Relationship: The exclusive partnership between Alexandria Real Estate Equities and Lilly, which has been ongoing since 2008, demonstrates a strong and collaborative relationship between the two companies. This partnership could have instilled confidence in investors regarding the stability and future prospects of Alexandria Real Estate Equities.
  • Overall, the bullish movement in ARE stock today can be attributed to the expansion of Lilly Gateway Labs, positive outlook, and the strong strategic relationship between Alexandria Real Estate Equities and Lilly.

14.10.2023 - ARE Stock was up 8.9%

  • The bullish movement in ARE's stock today can be attributed to the following factors:
  • 1. Collaboration with German publishing company C.H.Beck: The collaboration with C.H.Beck indicates ARE's continued efforts to expand its global presence and strengthen its position in the life science and technology sectors. This partnership could potentially lead to increased demand for ARE's properties, driving up the stock price.
  • 2. Positive assessment of investment potential: The article titled "Alexandria Real Estate Equities (ARE): A Smart Investment or a Value Trap? An In-Depth Exploration" suggests that investors are recognizing the long-term growth potential of ARE. This positive sentiment could be contributing to the bullish movement in the stock.
  • 3. Analysts' earnings forecasts: The article mentions that equities research analysts at Zacks Research have reduced their Q2 2024 earnings per share estimates for ARE. While this might seem like a negative factor, it is important to note that the stock market often reacts to analysts' forecasts differently. In this case, the market may have interpreted the reduced estimates as being better than expected, leading to a bullish movement in the stock.
  • Overall, the collaboration with C.H.Beck, positive assessment of investment potential, and the market's interpretation of analysts' forecasts could have contributed to the bullish movement in ARE's stock today.

22.07.2025 - ARE Stock was up 5.1%

  • ARE stock experienced a notable upward trend today, possibly influenced by optimistic market sentiment and investor confidence in the company's future growth prospects.
  • Despite a 3% decrease following the recent earnings release, investors seem hopeful about ARE's potential recovery, fuelled by forthcoming earnings projections and the company's focused approach towards high-demand real estate sectors.
  • The positive stock movement may also be linked to general market patterns or industry-specific factors that are bolstering real estate investments, thereby boosting ARE's stock value.

11.06.2024 - ARE Stock was up 5.1%

  • The bullish movement in ARE could be attributed to the overall positive sentiment towards undervalued REITs in the market.
  • The increase in dividends by publicly listed REITs in the U.S. and the selling of REITs at a discount to their net asset values may have contributed to the bullish trend in ARE.
  • The anticipation of a potential rate decrease by the Federal Reserve and the need for additional homes in the U.S. housing market could have further boosted investor confidence in REITs like ARE.
  • Investors looking to capitalize on the undervalued REITs with double-digit potential might have driven the strong bullish movement in ARE today.

10.03.2025 - ARE Stock was down 5.9%

  • Alexandria Real Estate Equities (ARE) experienced a strong bearish movement despite the recent surge in share price and higher trading volume.
  • The bullish trend in FFO estimate revisions may have initially boosted investor confidence, but other market factors or external news could have triggered profit-taking or a shift in sentiment.
  • It is essential for investors to closely monitor any developments that might impact the company's fundamentals or broader market conditions to make informed decisions in the face of short-term volatility.

29.03.2025 - ARE Stock was down 5.1%

  • ARE stock saw a significant downward movement today despite exceeding Q1 FFO and revenue expectations, highlighting a divergence between strong financial results and market response.
  • The market's adverse reaction may stem from concerns regarding future growth prospects or broader economic factors affecting the real estate industry.
  • Investors could be paying more attention to forward-looking guidance or potential obstacles the company may encounter, contributing to the bearish trajectory following the positive earnings outcome.
  • The difference between Wall Street's projections and actual performance in key metrics might have impacted investor sentiment, prompting the bearish shift in ARE stock.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.